These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3798406)

  • 21. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation.
    Chong BH; Pitney WR; Castaldi PA
    Lancet; 1982 Dec; 2(8310):1246-9. PubMed ID: 6128550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine A enhances platelet aggregation.
    Grace AA; Barradas MA; Mikhailidis DP; Jeremy JY; Moorhead JF; Sweny P; Dandona P
    Kidney Int; 1987 Dec; 32(6):889-95. PubMed ID: 3323604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis.
    Kondo K; Seo R; Naka M; Kitagawa T; Wakitani K; Sakata M; Kira H; Okegawa T; Kawasaki A
    Eur J Pharmacol; 1989 Apr; 163(2-3):253-61. PubMed ID: 2721574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.
    Fitzpatrick FA; Bundy GL; Gorman RR; Honohan T
    Nature; 1978 Oct; 275(5682):764-6. PubMed ID: 703845
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problems of a pharmacologic search for inhibitors of platelet aggregation].
    Lakin KM
    Kardiologiia; 1988 Oct; 28(10):120-6. PubMed ID: 3066962
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.
    Seuter F; Perzborn E; Rosentreter U; Böshagen H; Fiedler VB
    Arzneimittelforschung; 1989 Dec; 39(12):1525-7. PubMed ID: 2624599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1988; 101():125-36. PubMed ID: 3269674
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.
    Mikhailidis DP; Barradas MA; Maris A; Jeremy JY; Dandona P
    J Clin Pathol; 1985 Oct; 38(10):1166-71. PubMed ID: 3902901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
    Le Breton GC; Venton DL; Enke SE; Halushka PV
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1993 Dec; 63(4):521-3. PubMed ID: 8121085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ONO-3708: an effective thromboxane A2 antagonist possessing 3-acylaminopinane skeleton.
    Suga H; Hamanaka N; Kondo K; Miyake H; Ohuchida S; Arai Y; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():799-802. PubMed ID: 2960194
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local anesthetic actions on thromboxane-induced platelet aggregation.
    Lo B; Hönemann CW; Kohrs R; Hollmann MW; Polanowska-Grabowska RK; Gear AR; Durieux ME
    Anesth Analg; 2001 Nov; 93(5):1240-5. PubMed ID: 11682405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.